❌

Reading view

↗️

An open benchmark and language models for AI in aging biology

βœ‡Cell
By: Alex Zhavoronkov Β· Vladimir Naumov Β· Denis Sidorenko Β· Alex Aliper Β· Vladimir Aladinskiy Β· Ramin Hasani Β· Alexander Amini Β· Katerina Nasto Β· Mathieu Reymond Β· Rim Shayakhmetov Β· Zulfat Miftakhutdinov Β· Vadim N. Gladyshev Β· Fedor Galkin
LongevityBench, Longevity-LLMs, and Longevity Claw evaluate the readiness of the state-of-the-art AI systems for spearheading aging research.
  •  
  • ↗️
↗️

Integration of proteomic aging clocks in a phase 2a clinical trial supports simultaneous geroprotective assessment

βœ‡Nature Biotechnology - Issue - nature.com science feeds
By: Alex Zhavoronkov Β· Fedor Galkin Β· Shan Chen Β· Feng Ren Β· Alex Aliper Β· Mikhail Durymanov Β· Denis Sidorenko Β· Hui Cui Β· Jing-Dong J. Han Β· Hao Xu Β· Xiaodong Liu Β· Zuojun Xu Β· Christoph Kuppe Β· M. Austin Argentieri Β· Kejun Ying Β· Ludger J. E. Goeminne Β· Mahdi Moqri Β· Alexander Tyshkovskiy Β· Vadim N. Gladyshev

Nature Biotechnology, Published online: 07 September 2026; doi:10.1038/s41587-026-03286-y

Six proteomic clocks are applied in a clinical trial to assess anti-aging effects.
  •  
  • ↗️
There are no more articles
❌